Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1 H HR-MAS NMR spectroscopy
Roberta M. Maria, Wanessa Fernanda Altei, Heloísa Sobreiro Selistre-de-Araújo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 146, pp. 324-328
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen, Shangwu Chen, Dongsheng Yu
Metabolites (2020) Vol. 10, Iss. 7, pp. 289-289
Open Access | Times Cited: 97
Proton MR spectroscopy in the breast: Technical innovations and clinical applications
Reza Fardanesh, Maria Adele Marino, Daly Avendaño, et al.
Journal of Magnetic Resonance Imaging (2019) Vol. 50, Iss. 4, pp. 1033-1046
Open Access | Times Cited: 67
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism
Uma Sharma, N. R. Jagannathan
Metabolites (2022) Vol. 12, Iss. 4, pp. 295-295
Open Access | Times Cited: 30
The Importance of Being Casiopeina as Polypharmacologycal Profile (Mixed Chelate–Copper (II) Complexes and Their In Vitro and In Vivo Activities)
Zenayda Aguilar-Jiménez, Adrián Espinoza-Guillén, Karen Reséndiz-Acevedo, et al.
Inorganics (2023) Vol. 11, Iss. 10, pp. 394-394
Open Access | Times Cited: 21
A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
Marcella R. Cardoso, Juliana C. Santos, Marcelo Lima Ribeiro, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 617-617
Open Access | Times Cited: 40
Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
O. Zidi, Nessrine Souai, Henda Raies, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 27
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study
Zhihao Fang, Guohong Ren, Shouyu Ke, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer
Vittoria Marchio, Giuseppina Augimeri, Catia Morelli, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
Tomonori Sato, Yoshihide Kawasaki, Masamitsu Maekawa, et al.
Metabolites (2020) Vol. 11, Iss. 1, pp. 1-1
Open Access | Times Cited: 30
Breast Cancer with Increased Drug Resistance, Invasion Ability, and Cancer Stem Cell Properties through Metabolism Reprogramming
Kian-Hwee Chong, Yao-Jen Chang, Wei-Hsin Hsu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12875-12875
Open Access | Times Cited: 18
Cell Metabolomics to Guide the Design of Metal-Based Compounds
Veronica Ghini
Inorganics (2024) Vol. 12, Iss. 6, pp. 168-168
Open Access | Times Cited: 3
GC–MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel
Mohammad H. Semreen, Hasan Y. Alniss, Stefano Cacciatore, et al.
Journal of Proteomics (2020) Vol. 225, pp. 103875-103875
Closed Access | Times Cited: 23
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
Tatiana J. Carneiro, Ana L. M. Batista de Carvalho, Martin Vojtek, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Cancer Drug Resistance and Metabolic Reprogramming
Shariqa Jan, Kaneez Fatima, Abubakar Wani, et al.
(2024), pp. 183-214
Closed Access | Times Cited: 2
Multi-Organ NMR Metabolomics to Assess In Vivo Overall Metabolic Impact of Cisplatin in Mice
Tatiana J. Carneiro, Rita Araújo, Martin Vojtek, et al.
Metabolites (2019) Vol. 9, Iss. 11, pp. 279-279
Open Access | Times Cited: 18
High‐resolution magic angle spinning NMR for intact biological specimen analysis: Initial discovery, recent developments, and future directions
Leo L. Cheng
NMR in Biomedicine (2021) Vol. 36, Iss. 4
Closed Access | Times Cited: 15
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
Mariana Gallo, Elena Ferrari, Anna Terrazzan, et al.
FEBS Journal (2023) Vol. 290, Iss. 22, pp. 5411-5433
Open Access | Times Cited: 6
Modification of Proliferation and Apoptosis in Breast Cancer Cells by Exposure of Antioxidant Nanoparticles Due to Modulation of the Cellular Redox State Induced by Doxorubicin Exposure
Laura Denise López-Barrera, Roberto Díaz‐Torres, Joselo Ramón Martínez-Rosas, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1251-1251
Open Access | Times Cited: 13
The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment
Domenica Berardi, Yasmin Hunter, Lisa van den Driest, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3661-3661
Open Access | Times Cited: 8
Iso-seco-tanapartholide from Artemisia argyi inhibits the PFKFB3-mediated glycolytic pathway to attenuate airway inflammation in lipopolysaccharide-induced acute lung injury mice
Min Kong, Dongrong Zhu, Junyi Dong, et al.
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115781-115781
Closed Access | Times Cited: 8
Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?
Magesh Muthu, Anders Nordström
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1385-1385
Open Access | Times Cited: 13
In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla
Wiesław Guz, Rafał Podgórski, Zuzanna Bober, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1719-1719
Open Access | Times Cited: 1
Prognostic and predictive value of monocarboxylate transporter 4 in patients with breast cancer
Sheng Xiao, Hongjia Zhu, Yujun Shi, et al.
Oncology Letters (2020) Vol. 20, Iss. 3, pp. 2143-2152
Open Access | Times Cited: 11
Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids
Ângela R. Guerra, Ana Paulino, Maria M. Castro, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1163-1163
Open Access | Times Cited: 11
Breast Cancer Metabolomics Using NMR
Uma Sharma, N. R. Jagannathan
Methods in molecular biology (2019), pp. 195-213
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top